March 02, 2021
Article
The statement comes on the same day as a rare production agreement between pharmaceutical rivals, and Texas' announced lift of spread mitigation measures.
February 25, 2021
The new trial comes at a time when the FDA has provided guidance on navigating immunogenicity trials for vaccines designed against more transmissible SARS-CoV-2 strains.
February 24, 2021
A massive assessment of a quickly vaccinated population shows the mRNA vaccine provides greater protection over time.
February 23, 2021
TicoVac will be decided on for both pediatric and adult people at risk of the tick-borne virus in August.
February 22, 2021
The new advisory is informed by currently-understood effect of authorized vaccines against circulating SARS-CoV-2—which show benefit nonetheless.
February 20, 2021
The news comes on the same day as new data showing the vaccine's efficacy as a single-dose prophylactic, as well as the company's application for eased storage standards for US supplies.
February 18, 2021
This indispensable personal protective equipment did come up in short supply and reuse strategies has become a topic of great interest and research.
February 14, 2021
New South Africa-based data show not only lessened protection versus the region's dominant variant, but a reduced vaccine-induced antibody neutralization.
February 11, 2021
A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
February 08, 2021
The two-dose vaccine's ineffective prevention of the more transmissible virus variant led to official seeking better options—and broader outcomes.
